APA (7th ed.) Citation

N, I., Y, F., S, K., M, I., A, G., H, Y., . . . M, A. (2026). Dual-antigen recognition iPSC-derived CAR-T cells for B-cell malignancies: Establishment of a COVID-19 vaccine synergy strategy. Frontiers in cell and developmental biology, 14, 1772146. https://doi.org/10.3389/fcell.2026.1772146

Chicago Style (17th ed.) Citation

N, Izumi, Furukawa Y, Kinoshita S, Ishii M, Goto A, Yasuda H, Ando J, Nakauchi H, and Ando M. "Dual-antigen Recognition IPSC-derived CAR-T Cells for B-cell Malignancies: Establishment of a COVID-19 Vaccine Synergy Strategy." Frontiers in Cell and Developmental Biology 14 (2026): 1772146. https://doi.org/10.3389/fcell.2026.1772146.

MLA (9th ed.) Citation

N, Izumi, et al. "Dual-antigen Recognition IPSC-derived CAR-T Cells for B-cell Malignancies: Establishment of a COVID-19 Vaccine Synergy Strategy." Frontiers in Cell and Developmental Biology, vol. 14, 2026, p. 1772146, https://doi.org/10.3389/fcell.2026.1772146.